PEAK6’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Buy
3,640
+858
+31% +$550K ﹤0.01% 1352
2025
Q4
$1.88M Sell
2,782
-409
-13% -$279K ﹤0.01% 1466
2025
Q3
$2.04M Buy
3,191
+3,189
+159,450% +$1.94M ﹤0.01% 1490
2025
Q2
$1.02K Sell
2
-245
-99% -$117K ﹤0.01% 2843
2025
Q1
$104K Sell
247
-657
-73% -$285K ﹤0.01% 2596
2024
Q4
$374K Buy
+904
New +$397K ﹤0.01% 2295

Other funds holding IDXX

PEAK6's IDXX Position: Q1 2026 in Review

PEAK6 increased its Idexx Laboratories (IDXX) stake by 31% in Q1 2026, buying an estimated $550K and bringing the position to 3,640 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

PEAK6 first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • PEAK6 held 3,640 shares of Idexx Laboratories worth $2.05M as of Q1 2026.
  • PEAK6 bought 858 Idexx Laboratories shares in Q1 2026, an estimated $550K.
  • Idexx Laboratories made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #1352 holding.
  • PEAK6 first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.